HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
The Latest in Myeloma Therapy Advances with Sagar Lonial, MD, Winship Cancer Institue, Emory University
The Latest in Myeloma Therapy Advances with Sagar Lonial, MD, Winship Cancer Institue, Emory University image
HealthTree Podcast for Multiple Myeloma
event Jul 19, 2017 / 11:00AM - 12:00PM MDT

Event Description

Sagar Lonial, MD Winship Cancer Institute Interview Date: July 19, 2017

Recent meetings held this summer had important updates in multiple myeloma therapy. Renown myeloma expert Sagar Lonial, MD of the Winship Cancer Institute joins Myeloma Crowd Radio to share the latest in developments for newly diagnosed, relapsed/refractory, elderly and high-risk patients.  He stressed the importance of using both the immunomodulator and proteasome inhibitors in combinations - typically in triplets as induction therapy. Dr. Lonial also stressed the need to keep stem cell transplant in the mix of therapies to potentially get the "cure fraction" of patients to a higher percentage. He noted the introduction of quad therapies - or the addition of one of the monoclonal antibodies - and the need to balance treatment with toxicities. The nice part about adding a drug like elotuzumab or daratumumab is greater impact with minimal extra toxicities. He noted the excitement around the CAR T cell therapies with BCMA as a target. He emphasized the need for genetic testing at the beginning of diagnosis because he sets a 5-10 year strategy for his patients based on their type of myelolma. For high-risk patients, this would mean a longer maintenance period. 

Thanks to our episode sponsor


multiple myeloma


Schedule & Agenda

Dr. Sagar Lonial & Jenny Ahlstrom

Speakers & Moderators

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


+1 800 709 1113


Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube